The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Maintenance targeted therapy compared to standard of care (SoC) in patients (pts) with metastatic non-small cell lung cancer (NSCLC): Results from the phase II randomized UNICANCER/IFCT1301- SAFIR02-LUNG intergroup trial.
 
Benjamin Besse
Research Funding - 4D Pharma (Inst); Abbvie (Inst); Amgen (Inst); Aptitude Health (Inst); AstraZeneca (Inst); BeiGene (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Cergentis (Inst); Cristal Therapeutics (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Inivata (Inst); Janssen Oncology (Inst); Lilly (Inst); Onxeo (Inst); OSE Immunotherapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst)
 
Maryam Karimi
No Relationships to Disclose
 
Pascale Tomasini
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche; Takeda
Research Funding - Daiichi Sankyo Europe GmbH; Johnson & Johnson; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche; Takeda
 
Henri Janicot
No Relationships to Disclose
 
Judith Raimbourg
No Relationships to Disclose
 
Clarisse Audigier-Valette
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche
 
Anne Madroszyk
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Francois Chomy
Honoraria - AstraZeneca; Takeda
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Pfizer
 
Eric Dansin
Honoraria - Merck; Roche
Consulting or Advisory Role - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Julien Mazieres
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; Hengrui Therapeutics; Lilly/ImClone; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Alexis Cortot
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novartis; Pfizer; Roche; Takeda
Research Funding - Merck Serono (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; Roche
 
Ivan Bieche
No Relationships to Disclose
 
Ludovic Lacroix
No Relationships to Disclose
 
Sandrine Boyault
No Relationships to Disclose
 
Isabelle Soubeyran
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Pfizer
Consulting or Advisory Role - Bayer; Takeda
Travel, Accommodations, Expenses - Roche
 
Alain Morel
Research Funding - AstraZeneca (Inst)
 
Alicia Tran-Dien
No Relationships to Disclose
 
Alexandra Jacquet
No Relationships to Disclose
 
Jean-Charles Soria
Employment - AstraZeneca
Leadership - Hookipa Pharma (Inst)
Stock and Other Ownership Interests - AstraZeneca; Daiichi Sankyo; Gritstone Bio; Relay Therapeutics
Honoraria - Relay Therapeutics
Consulting or Advisory Role - Relay Therapeutics
 
Fabrice Barlesi
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Gentech; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Gentech (I); Innate Pharma (Inst); Ipsen (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Gentech; MSD Oncology; Roche